Author/Authors :
Akbarzadeh, Zahra Department of Community Nutrition - School of Nutrition and Food Science - Isfahan University of Medical Sciences, Isfahan , Parvaresh, Farnaz Department of Community Nutrition - School of Nutrition and Food Science - Isfahan University of Medical Sciences, Isfahan , Ghiasvand, Reza Department of Community Nutrition - School of Nutrition and Food Science - Isfahan University of Medical Sciences, Isfahan , Miraghajani, Maryam Shahid Beheshti University of Medical Sciences, Tehran
Abstract :
Background: Breast cancer is the most common cancer in women worldwide.
Recently, natural remedies such as Naringenin (Nar) - a kind of flavonoids which
can be found in grapefruits, oranges, and tomatoes - seem to be interesting. They
play a useful role in treatment and chemoprevention because of having pleiotropic
molecular mechanisms of action on breast cancer cells.
Methods:We performed a PRISMA-directed systematic review to investigate
the effects of Naringenin on some human breast cancer cells (MCF-7, T47D, and
MDA-MB-231). Tumor size, apoptosis, estrogenic properties, and cytotoxicity
were assessed as primary outcomes. The systematic search without restriction was
conducted in electronic databases, including PubMed, Scopus, Google scholar,
and Cochrane Library.
Results: Initially, 6445 articles were identified. After screening their titles and
abstracts, 32 studies were selected for text appraisal. Finally, 6 articles which met
the inclusion criteria were evaluated. Based on the evaluation, Nar could inhibit
both cell proliferation and tumor growth at different concentration. Moreover, it
could induce apoptosis.
Conclusions: Due to anticancer properties of Nar, some probable mechanisms
of these effects are induction of alteration in aromatase and caspase enzymes, and
suppression of oestrogen signal transduction pathways. However, more
investigations are necessary in the future to decide whether Nar consumption is
recommendable as part of breast cancer treatment and control. Also, some clinical
trials should be designed to determine the optimal dose for the therapeutic use.